Literature DB >> 22760297

Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).

Takuya Suga1, Takahiro Ishii, Masato Iwatsuki, Tsuyoshi Yamamoto, Kenichi Nonaka, Rokuro Masuma, Hidehito Matsui, Hideaki Hanaki, Satoshi Omura, Kazuro Shiomi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22760297     DOI： 10.1038/ja.2012.53

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  9 in total

1.  Euvesperins A and B, new circumventors of arbekacin resistance in MRSA, produced by Metarhizium sp. FKI-7236.

Authors:  Mayu Shiina; Takuya Suga; Yukihiro Asami; Kenichi Nonaka; Masato Iwatsuki; Satoshi Omura; Kazuro Shiomi
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

2.  Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.

Authors:  Kazushige Sasaki; Yoshihiko Kobayashi; Takashi Kurihara; Yohei Yamashita; Yoshiaki Takahashi; Toshiaki Miyake; Yuzuru Akamatsu
Journal:  J Antibiot (Tokyo)       Date:  2015-05-20       Impact factor: 2.649

3.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

4.  Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis.

Authors:  Melisa J Willby; Keith D Green; Chathurada S Gajadeera; Caixia Hou; Oleg V Tsodikov; James E Posey; Sylvie Garneau-Tsodikova
Journal:  ACS Chem Biol       Date:  2016-04-07       Impact factor: 5.100

5.  Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022.

Authors:  Takuya Suga; Mayu Shiina; Yukihiro Asami; Masato Iwatsuki; Tsuyoshi Yamamoto; Kenichi Nonaka; Rokuro Masuma; Hidehito Matsui; Hideaki Hanaki; Susumu Iwamoto; Hideyuki Onodera; Kazuro Shiomi; Satoshi Ōmura
Journal:  J Antibiot (Tokyo)       Date:  2016-06-22       Impact factor: 2.649

Review 6.  Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.

Authors:  Kristin J Labby; Sylvie Garneau-Tsodikova
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

7.  Prospects for Antibacterial Discovery and Development.

Authors:  Thomas M Privalsky; Alexander M Soohoo; Jinhua Wang; Christopher T Walsh; Gerard D Wright; Eric M Gordon; Nathanael S Gray; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2021-12-03       Impact factor: 15.419

8.  Metabolites from the Marine-Facultative Aspergillus sp. MEXU 27854 and Gymnoascus hyalinosporus MEXU 29901 from Caleta Bay, Mexico.

Authors:  Manuel A Aparicio-Cuevas; María Del Carmen González; Huzefa Raja; Isabel Rivero-Cruz; Steven J Kurina; Joanna E Burdette; Nicholas H Oberlies; Mario Figueroa
Journal:  Tetrahedron Lett       Date:  2019-05-20       Impact factor: 2.415

9.  Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (III).

Authors:  Yan Liu; Nina M Haste; Wdee Thienphrapa; Jerry Li; Victor Nizet; Mary Hensler; Rongshi Li
Journal:  Mar Drugs       Date:  2014-04-30       Impact factor: 5.118
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.